ArticleCureus2025
Co-occurrence of Cognitive Dysfunction and Depressive Disorders in Hemodialysis Patients: Demographic Patterns and Unmet Diagnostic Needs.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cognitive impairment and depressive disorders are common yet under-recognized comorbidities among patients with chronic kidney disease (CKD) undergoing dialysis. Moreover, life orientation, ranging from optimism to pessimism, plays a substantive role in modulating both clinical and psychosocial outcomes. This pilot cross-sectional study, conducted in Lucknow, India, assessed cognitive function, psychological outlook, and depressive symptoms among patients undergoing hemodialysis using the Montreal Cognitive Assessment (MoCA), the Life Orientation Test-Revised (LOT-R), and the Patient Health Questionnaire-9 (PHQ-9). Results indicated that 41% had mild cognitive impairment (MCI) and 10% had moderate cognitive impairment. Depression was widely observed in the sample, with 58% of patients presenting moderate symptoms and 7% experiencing moderately severe depressive levels. A pessimistic life orientation was reported by 32% of participants, while only 6% demonstrated strong optimism. Individuals aged 46-60 years and male patients showed a disproportionately higher level of cognitive and psychological difficulties. Additionally, comorbid diabetes (53%) and hypertension (67%) were significantly linked to adverse clinical and psychosocial outcomes. These findings align with global literature reporting a cognitive impairment prevalence of up to 80% in dialysis populations and high depression rates ranging from 13% to 76%. Despite their high prevalence, these conditions remain underdiagnosed in nephrology practice. The study underscores the need for routine cognitive and psychological assessment in dialysis units and early psychosocial interventions and informs the design of larger multicenter studies. Integrating such care could improve patient adherence, safety, and overall quality of life among patients with CKD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.